Vlahov D - Search Results

1

Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.

Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Markham RB, et al. Among authors: vlahov d. J Infect Dis. 1995 Apr;171(4):797-804. doi: 10.1093/infdis/171.4.797. J Infect Dis. 1995. PMID: 7706805

2

Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression.

Künzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. Künzi MS, et al. Among authors: vlahov d. J Infect Dis. 1995 Apr;171(4):822-8. doi: 10.1093/infdis/171.4.822. J Infect Dis. 1995. PMID: 7706808

3

Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.

Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE. Farzadegan H, et al. Among authors: vlahov d. J Infect Dis. 1993 Aug;168(2):327-31. doi: 10.1093/infdis/168.2.327. J Infect Dis. 1993. PMID: 8335969

4

The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.

Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM. Manoff SB, et al. Among authors: vlahov d. J Infect Dis. 1996 Aug;174(2):299-308. doi: 10.1093/infdis/174.2.299. J Infect Dis. 1996. PMID: 8699059

5

Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.

Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF. Markham RB, et al. Among authors: vlahov d. J Virol. 1996 Oct;70(10):6947-54. doi: 10.1128/JVI.70.10.6947-6954.1996. J Virol. 1996. PMID: 8794338 Free PMC article.

6

Vitamin A levels and human immunodeficiency virus load in injection drug users.

Semba RD, Farzadegan H, Vlahov D. Semba RD, et al. Among authors: vlahov d. Clin Diagn Lab Immunol. 1997 Jan;4(1):93-5. doi: 10.1128/cdli.4.1.93-95.1997. Clin Diagn Lab Immunol. 1997. PMID: 9008289 Free PMC article.

7

Vitamin A supplementation and human immunodeficiency virus load in injection drug users.

Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D. Semba RD, et al. Among authors: vlahov d. J Infect Dis. 1998 Mar;177(3):611-6. doi: 10.1086/514235. J Infect Dis. 1998. PMID: 9498439 Clinical Trial.

8

Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.

Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB. Yu XF, et al. Among authors: vlahov d. J Infect Dis. 1998 Aug;178(2):388-96. doi: 10.1086/515646. J Infect Dis. 1998. PMID: 9697718

9

Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.

Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF. Markham RB, et al. Among authors: vlahov d. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12568-73. doi: 10.1073/pnas.95.21.12568. Proc Natl Acad Sci U S A. 1998. PMID: 9770526 Free PMC article.

10

Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand.

Wang Z, Lyles CM, Beyrer C, Celentano DD, Vlahov D, Natpratan C, Markham R, Khamboonruang C, Nelson K, Yu XF. Wang Z, et al. Among authors: vlahov d. J Infect Dis. 1998 Nov;178(5):1507-11. doi: 10.1086/314441. J Infect Dis. 1998. PMID: 9780276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters